Seebri Neohaler Side Effects
Generic name: glycopyrrolate
Medically reviewed by Drugs.com. Last updated on Mar 14, 2024.
Note: This document contains side effect information about glycopyrrolate. Some dosage forms listed on this page may not apply to the brand name Seebri Neohaler.
Applies to glycopyrrolate: inhalation solution. Other dosage forms:
Serious side effects of Seebri Neohaler
Along with its needed effects, glycopyrrolate (the active ingredient contained in Seebri Neohaler) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking glycopyrrolate:
Less common
- Bladder pain
- bloating or swelling of the face, arms, hands, lower legs, or feet
- bloody or cloudy urine
- difficult, burning, or painful urination
- difficult or labored breathing
- frequent urge to urinate
- lower back or side pain
- rapid weight gain
- tightness in the chest
- tingling of the hands or feet
- unusual weight gain or loss
Rare
- Fast heartbeat
- fever
- hives, itching, or skin rash
- hoarseness
- irritation
- joint pain, stiffness, or swelling
- redness of the skin
- troubled swallowing
Incidence not known
- Blindness
- blurred vision
- decrease in the frequency of urination
- decrease in the urine volume
- decreased vision
- difficulty in passing urine (dribbling)
- eye pain or discomfort, or red eyes
- headache
- large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
- nausea
- seeing halos around lights
- tearing
- vomiting
Other side effects of Seebri Neohaler
Some side effects of glycopyrrolate may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
- Body aches or pain
- chills
- cough
- ear congestion
- loss of voice
- pain or tenderness around the eyes and cheekbones
- sneezing
- sore throat
- stuffy or runny nose
- unusual tiredness or weakness
Rare
- Diarrhea
- dry mouth
- flushed, dry skin
- fruit-like breath odor
- increased hunger
- increased thirst
- increased urination
- loss of appetite
- loss of consciousness
- pain in the arms or legs
- stomachache
- sweating
- trouble sleeping
- unexplained weight loss
- weakness
For Healthcare Professionals
Applies to glycopyrrolate: compounding powder, inhalation capsule, inhalation solution, injectable solution, intravenous solution, oral solution, oral tablet, oral tablet disintegrating.
Gastrointestinal
Very common (10% or more): Dry mouth (40%), vomiting (40%), constipation (35%)
Frequency not reported: Abdominal distension, abdominal pain, stomach discomfort, chapped lips, flatulence, retching, dry tongue[Ref]
Cardiovascular
Very common (10% or more): Flushing (30%)
Frequency not reported: Heart rate increase, pallor[Ref]
Nervous system
Very common (10% or more): Headache (15%)
Frequency not reported: Convulsion, dysgeusia, nystagmus
Postmarketing reports: Loss of taste[Ref]
Genitourinary
Very common (10% or more): Urinary retention (15%)
Postmarketing reports: Suppression of lactation[Ref]
Immunologic
Very common (10% or more): Sinusitis (15%), upper respiratory tract infection (15%)
Frequency not reported: Pneumonia, tracheostomy infection, urinary tract infection[Ref]
Respiratory
Very common (10% or more): Nasal congestion (30%)
Frequency not reported: Increased viscosity of bronchial secretion, nasal dryness[Ref]
Psychiatric
Frequency not reported: Irritability, agitation, restlessness, abnormal behavior, aggression, crying, impulse control disorder, moaning, mood altered[Ref]
Dermatologic
Frequency not reported: Dry skin, pruritus, rash[Ref]
Metabolic
Frequency not reported: Dehydration[Ref]
Other
Frequency not reported: Pain[Ref]
Frequently asked questions
More about Seebri Neohaler (glycopyrrolate)
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anticholinergic bronchodilators
- Breastfeeding
Patient resources
Other brands
Robinul, Cuvposa, Robinul Forte, Dartisla ODT, ... +2 more
Professional resources
Other brands
Robinul, Cuvposa, Dartisla ODT, Glyrx-PF, Lonhala Magnair
Related treatment guides
References
1. Product Information. Cuvposa (glycopyrrolate). Shionogi USA Inc. 2010.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.